Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome.
作者信息
Wais V, Kündgen L, Bohl S R, von Harsdorf S, Schlenk R F, Döhner K, Teleanu V, Bullinger L, Nguyen T M, Drognitz K, Moulin J-C, Binnenhei M, Bentz M, Döhner H, Bunjes D, Kuchenbauer F, Ringhoffer M
机构信息
Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany.
出版信息
Bone Marrow Transplant. 2018 Jan;53(1):94-96. doi: 10.1038/bmt.2017.211. Epub 2017 Nov 13.
PMID:29131153
Abstract
摘要
Zotero 插件